Standardized GMP-compliant scalable production of human pancreas organoids.

Marta DossenaRoberta PirasAlessandro CherubiniMario BarilaniErica DugnaniFrancesca SalanitroTill MorethFrancesco PampaloniLorenzo PiemontiLorenza Lazzari

Published in: Stem cell research & therapy (2020)

This work represents a milestone for a GMP-compliance hPO production and, ultimately, their clinical application as a type 1 diabetes therapy.

Keyphrases

type diabetes
induced pluripotent stem cells
endothelial cells
biofilm formation
cardiovascular disease
glycemic control
stem cells
insulin resistance
pseudomonas aeruginosa
escherichia coli
mesenchymal stem cells
bone marrow
staphylococcus aureus
cystic fibrosis
smoking cessation